{"transactions":[{"id":924597,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":68185,"kind":"person","name":"Conn Avi Daniel","position":1,"cik":"0002064982","reported_name":"Conn Avi Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-02T21:30:14.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest and become exercisable in equal monthly installments over 48 months commencing on January 29, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":45000,"derivative":{"exercise_price":3.9,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0002064982-26-000002","document":"form4-02022026_040205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000206498226000002/form4-02022026_040205.xml","form_type":"4"}},{"id":962918,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":68185,"kind":"person","name":"Conn Avi Daniel","position":1,"cik":"0002064982","reported_name":"Conn Avi Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-18T22:00:11.000Z","date":"2025-12-16","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on December 16, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":17500,"derivative":{"exercise_price":4.2,"expiration_date":"2035-12-16","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0002064982-25-000003","document":"form4-12182025_051203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000206498225000003/form4-12182025_051203.xml","form_type":"4"}},{"id":1168256,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":68185,"kind":"person","name":"Conn Avi Daniel","position":1,"cik":"0002064982","reported_name":"Conn Avi Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-21T21:15:25.000Z","date":"2025-04-17","kind":"grant","planned":false,"acquired":true,"shares":43547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":43547,"derivative":{"exercise_price":17.04,"expiration_date":"2035-04-16","underlying":"Common Stock","underlying_shares":43547},"source":{"system":"sec-edgar","filing":"0001415889-25-011115","document":"form4-04212025_050421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588925011115/form4-04212025_050421.xml","form_type":"4"}},{"id":1169514,"issuer":{"id":7579,"kind":"organization","name":"Tvardi Therapeutics, Inc."},"owners":[{"id":68185,"kind":"person","name":"Conn Avi Daniel","position":1,"cik":"0002064982","reported_name":"Conn Avi Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-17T22:50:06.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":89053,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for a stock option to acquire 664,000 shares of common stock of Tvardi Therapeutics, Inc. (\"Legacy Tvardi\") with the exercise price of $0.63 per share pursuant to an Agreement and Plan of Merger and Reorganization by and among, the Issuer, CT Convergence Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\") and Legacy Tvardi, as amended (the \"Merger Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Under the terms of the Merger Agreement, on April 15, 2025, Merger Sub merged with and into Legacy Tvardi (the \"Merger\"), with Legacy Tvardi surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each outstanding option to purchase shares of Legacy Tvardi common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Cara Therapeutics, Inc. to Tvardi Therapeutics, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested on the one year anniversary of the vesting commencement date and the balance of the shares vested or will vest in a series of thirty-six (36) successive equal monthly installments measured from the first anniversary of the vesting commencement date."}],"balance_after":89053,"derivative":{"exercise_price":4.7,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":89053},"source":{"system":"sec-edgar","filing":"0001415889-25-010977","document":"form4-04172025_060403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346830/000141588925010977/form4-04172025_060403.xml","form_type":"4"}}]}